The California Peptide Club III
[Private Event. Access only when admitted]
The peptide moment is here.
12 peptides were just administratively reclassified out of Category 2, and the PCAC advisory panel will review 7 more in July.
Eli Lilly is suing the FDA over whether retatrutide is a drug or a biologic, and the outcome will determine whether the next generation of peptides is ever accessible.
And get to be right in the middle of it.
About the California Peptide Club
We’re building the community out of AGI House SF in which frontier physicians, peptide researchers and high-perfomers take their health into their own hands.
We’re not a biohacking conference or a wellness club. We remove information asymmetry by educating on peptide protocols, risks, their history and science.
Last time, we were 3x oversubscribed, so apply soon.
Pep Talks & Afterpepty
For our third gathering, we're spicing it up with live consultations (finally!), workshops on peptides, and more advanced panels as well.
Agenda
5:30 PM — Doors open.
6:00 PM — Co-Keynote: Peptides 101. Awais Spall (functional medicine practitioner) & Julius Ritter: We're taking a step back: What is a peptide? What are the most important ones? Why were they banned and what's happening at the FDA in July? This is specifically for people new to the world of peptides!
7:00 PM: Light Dinner and Snacks
7:30 PM — Community Pitches: 2 minute pitch of research projects, start-ups, political projects.
7:50 PM — Sourcing and Quality Assurance: Where to buy RUO peptides from and how to validate the quality
8:10 PM — Surprise Marquee Speaker
9 PM — Hangout, conversations
Our last events were oversubscribed, so please apply soon.